Aptus Pharma Limited, a active public limited company, was established on 12 August 2010 in Daskroi, Gujarat, India. Engaging in wholesale within the trade sector, it holds CIN: U24230GJ2010PLC061957. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹7.15 Cr and a paid-up capital of ₹6.86 Cr.
It upholds a compliant status. Employing 28 professional, Its leadership includes Riddhish Natwarlal Tanna (Director), Jyotiben Hasmukhbhai Chandarana (Director), Chetan Shantilal Lalseta (Director). Past directors included Nileshkumar Narbheshankar Thanki, Mayankbhai Rameshchandra Thakker, Tejal Tejasbhai Hathi. It holds ₹5.00 Cr open charges and ₹3.00 Cr settled loans. Its latest AGM occurred on 18 June 2025, with the balance sheet filed on 31 March 2025. It is based at Ashutosh Buildcon, Opp. Slok 2,, Nr. Harikrupa Logistic Park, Aslali,, Daskroi, Gujarat, 382427.
U24230GJ2010PLC061957
061957
12 August 2010
₹7.15 Cr
₹6.86 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Aptus Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Riddhish Natwarlal Tanna | Director | 17 Jan 2024 | Current |
| Jyotiben Hasmukhbhai Chandarana | Director | 20 May 2024 | Current |
| Chetan Shantilal Lalseta | Director | 17 Jan 2024 | Current |
| Tejash Maheshchandra Hathi | Managing Director | 12 Aug 2010 | Current |
| Sejal Harit Palan | Director | 06 Feb 2025 | Current |
| Vikas Rambhai Jobanputra | Director | 06 Feb 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Apr 2014 | Past |
| Pramod Abcsdd | Director | 29 Apr 2024 | Past |
| Pramod Abcsdd | Director | 29 Apr 2024 | Past |
| Pramod Abcsdd | Director | 29 Apr 2024 | Past |
| Pramod Abcsdd | Director | 29 Apr 2024 | Past |
| Pramod Abcsdd | Director | 16 Jan 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Aptus Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹29,985,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2024 | Others | ₹5.00 Cr | Open |
| 28 Apr 2023 | Hdfc Bank Limited | ₹2.00 Cr | Satisfied |
| 15 Jul 2020 | Others | ₹0.59 M | Satisfied |
| 02 Nov 2015 | Others | ₹8.00 M | Satisfied |
| 30 Aug 2012 | Central Bank Of India | ₹1.40 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Aptus Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aptus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aptus Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aptus Pharma Limited last Annual general meeting of members was held on 18 Jun 2025 as per latest MCA records. was documented.
Progress on Aptus Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
Progress on Sejal Harit Palan was appointed as a Director was appointed as a Director on 06 Feb 2025 & has been associated with this company since 9 months 25 days . was documented.
Progress on Vikas Rambhai Jobanputra was appointed as a Director was appointed as a Director on 06 Feb 2025 & has been associated with this company since 9 months 25 days . was documented.
The activity Ghanshyam Vinubhai Pansuriya was appointed as a Ceo was appointed as a Ceo on 24 Jan 2025 & has been associated with this company since 10 months 7 days . was completed.
The activity Kapilbhai Hasmukhbhai Chandarana was appointed as a Cfo was appointed as a Cfo on 24 Jan 2025 & has been associated with this company since 10 months 7 days . was completed.
The CIN of Aptus Pharma Limited is U24230GJ2010PLC061957.
Aptus Pharma Limited is headquartered at Ashutosh Buildcon, Opp. Slok 2,, Nr. Harikrupa Logistic Park, Aslali,, Daskroi, Gujarat, 382427.
Aptus Pharma Limited was incorporated on 12 August 2010.
The current directors of Aptus Pharma Limited are
The primary industry of Aptus Pharma Limited is Trade.
Aptus Pharma Limited is unlisted.
The authorized capital of Aptus Pharma Limited is ₹7.15 Cr, and the paid-up capital is ₹6.86 Cr.
The compliance status of Aptus Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX